dc.creator | Kornuta, Claudia Alejandra | |
dc.creator | Cheuquepan Valenzuel, Felipe Andres | |
dc.creator | Bidart, , Juan Esteban | |
dc.creator | Soria, Ivana | |
dc.creator | Gammella, Mariela | |
dc.creator | Quattrocchi, Valeria | |
dc.creator | Hecker, Yanina | |
dc.creator | Moore, Prando Dadin | |
dc.creator | Romera, Sonia Alejandra | |
dc.creator | Marin, Maia Solange | |
dc.creator | Zamorano, Patricia Ines | |
dc.creator | Langellotti, Cecilia Ana | |
dc.date.accessioned | 2021-12-10T17:07:29Z | |
dc.date.accessioned | 2023-03-15T14:12:33Z | |
dc.date.available | 2021-12-10T17:07:29Z | |
dc.date.available | 2023-03-15T14:12:33Z | |
dc.date.created | 2021-12-10T17:07:29Z | |
dc.date.issued | 2022-01 | |
dc.identifier | 0042-6822 | |
dc.identifier | https://doi.org/10.1016/j.virol.2021.11.014 | |
dc.identifier | http://hdl.handle.net/20.500.12123/10887 | |
dc.identifier | https://www.sciencedirect.com/science/article/abs/pii/S0042682221002397 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/6213854 | |
dc.description.abstract | The innate and acquired immune response induced by a commercial inactivated vaccine against Bovine Herpesvirus-1 (BoHV-1) and protection conferred against the virus were analyzed in cattle. Vaccination induced high levels of BoHV-1 antibodies at 30, 60, and 90 days post-vaccination (dpv). IgG1 and IgG2 isotypes were detected at 90 dpv, as well as virus-neutralizing antibodies. An increase of anti-BoHV-1 IgG1 in nasal swabs was detected 6 days post-challenge in vaccinated animals. After viral challenge, lower virus excretion and lower clinical score were observed in vaccinated as compared to unvaccinated animals, as well as BoHV-1-specific proliferation of lymphocytes and production of IFNγ, TNFα, and IL-4. Downregulation of the expression of endosome Toll-like receptors 8–9 was detected after booster vaccination. This is the first thorough study of the immunity generated by a commercial vaccine against BoHV-1 in cattle. | |
dc.language | eng | |
dc.publisher | Elsevier | |
dc.relation | info:eu-repograntAgreement/INTA/PNBIO-1131032/AR./Desarrollo de herramientas biotecnológicas para la prevención y el control de enfermedades pecuarias: vacunas, diagnóstico y eIdemiología molecular. | |
dc.rights | info:eu-repo/semantics/embargoedAccess | |
dc.source | Virology 566 : 98-105 (January 2022) | |
dc.subject | Ganado Bovino | |
dc.subject | Enfermedades de los Animales | |
dc.subject | Respuesta Inmunológica | |
dc.subject | Vacuna | |
dc.subject | Herpes Virus Bovino | |
dc.subject | Vacuna Inactivada | |
dc.subject | Cattle | |
dc.subject | Animal Diseases | |
dc.subject | Immune Response | |
dc.subject | Vaccines | |
dc.subject | Bovine Herpesvirus | |
dc.subject | Inactivated Vaccines | |
dc.title | TLR activation, immune response and viral protection elicited in cattle by a commercial vaccine against Bovine Herpesvirus-1 | |
dc.type | info:ar-repo/semantics/artículo | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/acceptedVersion | |